Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001829126-25-007289
Filing Date
2025-09-10
Accepted
2025-09-10 16:05:26
Documents
22
Period of Report
2025-10-16

Document Format Files

Seq Description Document Type Size
1 PRE 14A novabay_pre14a.htm   iXBRL PRE 14A 1236557
2 GRAPHIC img_001.jpg GRAPHIC 8608
3 GRAPHIC img_002.jpg GRAPHIC 85085
4 GRAPHIC img_003.jpg GRAPHIC 36823
5 GRAPHIC img_004.jpg GRAPHIC 37406
6 GRAPHIC proxy_001.jpg GRAPHIC 651073
7 GRAPHIC proxy_002.jpg GRAPHIC 388593
  Complete submission text file 0001829126-25-007289.txt   4846922

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE cik0001389545-20241231.xsd EX-101.SCH 5705
9 XBRL DEFINITION FILE cik0001389545-20241231_def.xml EX-101.DEF 9525
10 XBRL LABEL FILE cik0001389545-20241231_lab.xml EX-101.LAB 58737
11 XBRL PRESENTATION FILE cik0001389545-20241231_pre.xml EX-101.PRE 41926
24 EXTRACTED XBRL INSTANCE DOCUMENT novabay_pre14a_htm.xml XML 108036
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33678 | Film No.: 251305923
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)